Palette Makes It Possible
Unlocking Impossible Proteins for a Better World
The Protein Paradox
Designing next-gen proteins is no longer the problem.
Making them is.
Unlimited Protein Design.
Limited Ways to Make Them.
The explosion of synthetic biology and AI-driven protein design has outpaced our ability to produce those proteins. Today’s expression systems—E. coli, yeast, CHO—fail at complex, toxic, or heavily folded proteins. Innovation is stalled at the bench.
A New Expression Platform for a New Era.
We need a biomanufacturing system as advanced as the proteins we’re designing. Palette’s platform uses algal chloroplasts—harnessing novel biochemistry and cell-free capabilities—to express what others can't, safely and at scale.
Scaling the Impossible:
A New Era in Protein Manufacturing
Modern tools can design thousands of novel proteins — but few platforms can bring them to life. Palette has cracked the code. We’ve unlocked the full potential of algal chloroplasts — the world’s most abundant biochemical system — to safely express complex, bioactive, and even host-toxic proteins at scale. Our patented and proprietary platform allows scientists to manufacture the next generation of therapeutic and industrial proteins that traditional systems like E. coli, yeast, or CHO cells simply can't handle.
Why It Matters:
-
Unlimited design, limited delivery: Tools like AlphaFold and Rosetta enable custom protein design — but current expression systems can’t keep up.
-
From bottleneck to breakthrough: Palette’s platform acts as a biological containment chamber, isolating toxic proteins from host machinery for safe production.
-
Scalable and fermentation-ready: Unlike plant-based systems that rely on sunlight, our tech works with stainless steel fermenters — ready to meet industrial demand.
We don’t design “impossible” proteins — we make them, at scale.
Want to learn more?
Join us in unlocking what's possible.